Disseminating the results of clinical trials to community-based practitioners: Is anyone listening?

American Heart Journal

Volumn 137, Issue 1, 1999, Pages 4-7

  Goldberg, R J ^a   Gurwitz, J H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; CLINICAL RESEARCH; COMMUNITY MEDICINE; EDITORIAL; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; PRIORITY JOURNAL;

EID: 0032905754     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70453-9     Document Type: Editorial

References (31)

1. GISSI Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 1986 398 402
2. ISIS Steering Committee Intravenous streptokinase given within 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2 Lancet 1 1987 502
3. AIMS Trial Study Group Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial Lancet 1 1988 545 549
4. ISIS-1 First International Study of Infarct Survival Collaborative Group Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 1986 57 66
5. CH Hennekens CM Albert SL Godfried JM Gaziano JE Buring Adjunctive drug therapy of acute myocardial infarction: Evidence from clinical trials N Engl J Med 335 1996 1660 1667
6. S Yusuf R Peto J Lewis R Collins P Sleight Beta blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis 27 1985 335 371
7. ISIS-2 Second International Study Of Infarct Survival Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 2 1988 349 360
8. ISIS-4 Fourth International Study Of Infarct Survival Collaborative Group ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction Lancet 345 1995 669 685
9. Gruppo Italiano per Io Studio della Sopravvivenza nell’Infarto Miocardico GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction Lancet 343 1994 1115 1122
10. RM Gunnar PVD Bourdillon DW Dixon Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction) J Am Coll Cardiol 16 1990 249 292
11. ACC/AHA Task Force Guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Head Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 28 1996 1328 1428
12. National Cholesterol Education Program Expert Panel Report on detection, evaluation and treatment of high blood cholesterol in adults Arch Intern Med 148 1988 36 69
13. National Cholesterol Education Program Second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel II) Circulation 89 1994 1333 1445
14. TJ McLaughlin SB Soumerai DJ Willison JH Gurwitz C Borbas E Guadagnoli Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly Arch Intern Med 156 1996 799 805
15. H Krumholz Y Wang EM Parent J Mockalis M Petrillo MJ Radford Quality of care for elderly patients hospitalized with heart failure Arch Intern Med 157 1997 2242 2247
16. Clinical Quality Improvement Network Investigators Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex and medical therapy Arch Intern Med 156 1996 1669 1674
17. MA Konstam K Dracup D Baker M Bottorff NH Brooks RA Dacey Heart failure: evaluation and care of patients with left ventricular systolic dysfunction Clinical Practice Guidelines #11. AHCPR Publication No. 94-0612. Agency for Health Care Policy and Research 1994 U.S. Department of Health and Human Services Rockville, MD
18. JZ Ayanian E Guadagnoli BJ McNeil PD Cleary Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians Arch Intern Med 157 1997 2570 2576
19. TL Schreiber A Elkhatib CL Grines WW. O’Neil Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes J Am Coll Cardiol 26 1995 577 582
20. HR Kizer CP Cannon CH McCabe HS Mueller MJ Schweiger VG Davis Trends in the use of pharmacotherapies for acute myocardial infarction in relation to the published literature among physicians who design or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience Am Heart J 136 1998 79 92
21. JH Gurwitz RJ Goldberg Z Chen JM Gore JS Alpert Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly Am J Med 93 1992 605 610
22. PR Pagley J Yarzebski RJ Goldberg Z Chen D Chiriboga P Dalen Gender differences in the treatment of patients with acute myocardial infarction: a multi-hospital, community-based perspective Arch Intern Med 153 1993 625 629
23. J Yarzebski N Col P Pagley J Savageau JM Gore RJ Goldberg Gender differences and factors associated with the receipt of thrombolytic therapy in patients with acute myocardial infarction: a community-wide perspective Am Heart J 131 1996 44 49
24. D Ketley KL Woods Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction Lancet 342 1993 891 894
25. TC Chalmers The impact of controlled trials on practice of medicine Mt Sinai J Med 41 1974 753 759
26. HV Fineberg Clinical evaluation: how does it influence medical practice? Bull Cancer (Paris) 74 1987 333 346
27. D Ross-Degnan SB Soumerai EF Fortress JH Gurwitz Examining product risk in context: market withdrawal of zomepirac as a case study JAMA 270 1993 1937 1942
28. J Avorn Chen R Hartley Scientific versus commercial sources of influence on the prescribing behavior of physicians Am J Med 73 1982 4 8
29. SB Soumerai TJ McLaughlin JH Gurwitz E Guadagnoli PJ Hauptman C Borbas Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial JAMA 279 1998 1358 1363
30. CD Naylor Better care and better outcomes: the continuing challenge JAMA 279 1998 1392 1394
31. NF Col TJ McLaughlin SB Soumerai DW Hosmer Jr J Yarzebski JH Gurwitz The impact of clinical trials on the use of medications for acute myocardial infarction: results of a community-based study Arch Intern Med 156 1996 54 60